The simple answer is yes we should be treating latent myofascial trigger points (L-MTrP), but why?
Studies have shown the following:
L-MTrP may be responsible for less specific but highly disabling symptoms of muscle fatigue (Ge et al, 2013)
L-MTrP result in weakness and general dysfunction with EMG studies showing abnormal and inappropriate muscle co-activation where there are MTrP present in the prime acting muscle. This may result in the inability to perform smooth con-ordinated movements involving the synchrony of agonist and antagonist muscle groups.